Clinical Trials Logo

Excision Margin clinical trials

View clinical trials related to Excision Margin.

Filter by:
  • None
  • Page 1

NCT ID: NCT04918381 Completed - Clinical trials for BCC - Basal Cell Carcinoma

CellFX Treat & Resect Low-Risk BCC Feasibility Study

Start date: June 2, 2021
Phase: N/A
Study type: Interventional

This prospective, multicenter, study is designed to evaluate the safety and effectiveness of the CellFX System in adults subjects with low-risk basal cell carcinoma (superficial and nodular) for complete histological clearance of the target lesion followed by surgical tumor excision 60 days post-treatment.

NCT ID: NCT04344847 Recruiting - Excision Margin Clinical Trials

Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety Margin

Start date: December 12, 2016
Phase: N/A
Study type: Interventional

LSG is thought to be the best choice for obese patients with conincidental GISTs, as a tumour can be resected along with resecting the stomach within the same procedure. The primary endpoint is that, how much does GIST suppose to be far from a staple line to do safe laparoscopic sleeve gastrectomy